99%+ Purity
COA Included
Sealed Vials
PE-22-28
Neurogenesis peptide for cognitive enhancement
Neurogenesis and cognitive enhancement
Key Benefits
- May support new neuron growth
- Potentially enhances cognitive function
- Research suggests improved synaptic plasticity
- May promote neuronal survival pathways
- Could support healthy neuroinflammatory response
- Targets brain-derived neurotrophic factor signaling
- May enhance hippocampal neurogenesis
Want to purchase this peptide?
Think Faster, Remember More, Build New Brain Cells
Your brain stops making new neurons as you age—that's why thinking gets slower and memory gets fuzzy. PE-22-28 is designed to restart that neurogenesis process, giving you the mental sharpness and recall you had in your twenties. Instead of accepting cognitive decline, you're actually building new neural pathways.
Neurogenesis pathway / BDNF signaling cascade (hippocampal neuron formation, synaptic plasticity)
About PE-22-28
PE-22-28 is a synthetic neurogenesis peptide that targets brain-derived neurotrophic factor pathways to promote new neuron growth and enhance cognitive function. It works by activating the cellular machinery responsible for creating fresh neural connections in areas of the brain critical for memory and learning. The peptide is specifically designed to support hippocampal neurogenesis while promoting overall brain plasticity.
Who It's For
This peptide is for high-performers who need their cognitive edge maintained or restored—executives, entrepreneurs, and anyone whose livelihood depends on mental acuity. PE-22-28 represents a proactive approach to brain health, potentially preventing age-related cognitive decline while enhancing current mental performance. It integrates well with comprehensive longevity protocols focused on maintaining peak neurological function throughout aging.
Research Background
PE-22-28 represents an investigational peptide in the emerging field of neurogenesis enhancement, though comprehensive research data remains limited. The compound is designed to potentially stimulate the growth of new neurons and improve cognitive function by targeting key brain signaling pathways involved in neuroplasticity and synaptic connectivity. Research in this area focuses on understanding how specific peptide sequences can influence brain-derived neurotrophic factor (BDNF) pathways, which are crucial for neuron survival and growth.
Current research priorities include: 1) Establishing optimal peptide design for brain penetration, 2) Understanding long-term safety profiles, and 3) Determining effective dosing strategies. The field faces significant challenges related to blood-brain barrier penetration and peptide stability, which are common obstacles in neurological drug development. While the concept of pharmacologically enhancing neurogenesis shows promise in laboratory settings, translation to human applications requires extensive safety and efficacy validation through rigorous clinical research protocols.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 200-300 mcg | |
Intermediate | 300-500 mcg | |
Advanced | 500-600 mcg | |
Maximum | 750-1000 mcg |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
4
33.6 mg needed ÷ 10 per vial
Total Investment
$160
$40.00 per vial
Per Dose
0.08 mL
8 units on U-100 syringe
Doses per Vial
25
10 ÷ 0.40 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Educational Resources
Download educational materials and research documentation for PE-22-28.
PE-22-28 Cheat Sheet
Dosing protocols, reconstitution & storage guide
Featured in These Stacks
NEURO & COGNITIVE STACK INVENTORY
NEURO & COGNITIVE STACK
The Neuro & Cognitive Inventory is not about stimulation. It is about regulation and optimization. Most people try to solve productivity and performance with caffeine, stimulants, or brute-force effort. That approach creates spikes and crashes. This stack improves signal quality inside the brain — enhancing communication, resilience, and clarity rather than forcing output. When cognitive signaling is stable: Training consistency improves Protocol adherence increases Stress tolerance strengthens Sleep architecture stabilizes Perceived performance improves In a peptide business model, this axis protects outcomes. A client who feels sharper, calmer, and more focused is more likely to continue, upgrade, and refer. Core Neuro & Cognitive Components 🧠 IllumiNeuro Multi-pathway cognitive blend supporting focus, mood balance, and neurological signaling efficiency. 🧠 Pinealon Short-chain neuroregulatory peptide supporting neuronal gene expression and brain cell stability. 🧠 PE-22-28 Mood-modulating peptide associated with BDNF-related pathways and emotional resilience. 🧠 Selank Anxiolytic peptide supporting calm focus and stress regulation. 🧠 Semax Cognitive enhancer associated with memory, attention, and neuroplasticity support. Strategic Role Inside the Stack The Neuro axis does not replace Metabolic, GH, or Mito — it enhances them. Fat loss improves when stress is controlled Recovery improves when sleep stabilizes Recomposition improves when adherence increases Longevity positioning strengthens when cognitive resilience improves This is the layer that supports behavioral execution. Business Positioning At scale, the Neuro & Cognitive stack: Increases client retention Improves satisfaction perception Supports executive clientele Adds premium differentiation Expands average order value It is not about hype. It is about signal quality. The body performs better when the brain coordinates better. That’s the leverage point.
Includes
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
